Holen Sie sich die Stockscreener-App
166.86
2.78%
4.51
Handel nachbörslich:
166.86
Schlusskurs vom Vortag:
$162.35
Offen:
$163.93
24-Stunden-Volumen:
851.24K
Relative Volume:
1.70
Marktkapitalisierung:
$5.36B
Einnahmen:
$560.03M
Nettoeinkommen (Verlust:
$-150.66M
KGV:
-34.33
EPS:
-4.86
Netto-Cashflow:
$-87.43M
1W Leistung:
+6.95%
1M Leistung:
+22.75%
6M Leistung:
+48.73%
1J Leistung:
+150.99%
1-Tages-Spanne:
$163.38
$168.09
1-Wochen-Bereich:
$156.06
$168.09
52-Wochen-Spanne:
$55.92
$168.32
Irhythm Technologies Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Technologies Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Vergleichen Sie IRTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
166.86 | 5.22B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Technologies Inc Aktie (IRTC) Neueste Nachrichten
Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know - uk.finance.yahoo.com
Local health-tech startup secures $2.3M to accelerate AI tools, double workforce - The Business Journals
IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook - FinancialContent
Morgan Stanley Raises iRhythm (IRTC) Price Target, Maintains Overweight Rating - MSN
Artificial Intelligence in Remote Patient Monitoring Market - openPR.com
Artificial Intelligence in Remote Patient Monitoring Market Poised to Grow at 27.13% CAGR Through 2032, Reports DelveInsight | Medtronic, iRhythm, Philips, Siemens Healthineers, GE HealthCare, etc - Barchart.com
Morgan Stanley Maintains Buy Rating for Irhythm Technologies with $195 Price Target - AInvest
Chad Patterson Sells 2,555 Shares of iRhythm Technologies Inc, Modestly Overvalued According to GF Value - AInvest
Don't Ignore The Insider Selling In iRhythm Technologies - simplywall.st
iRhythm Technologies' Chief Commercial Officer Sells 2,555 Shares - AInvest
AI Tracker: Study says chatbots don’t flag bad health information - Modern Healthcare
iRhythm Fails to Halt Information Exchange in Investor Lawsuit - Bloomberg Law News
Top Executives Cash Out Big on Irhythm Technologies Stock! - TipRanks
Top Executives Cash Out on Irhythm Technologies Stock Amid Strong Earnings and Raised Price Targets. - AInvest
Stewart Won't Reconsider Her 1st Settled Expectations Denial - Law360
Stewart Denies iRhythm’s Bid to Review Decision Scrapping IPRs Based on ‘Settled Expectations’ - IPWatchdog.com
Insider Selling at iRhythm Technologies: Signal or Noise in a High-Flying Stock? - AInvest
Truist Financial Reiterates Buy Rating for Irhythm Technologies with $175 Price Target - AInvest
iRhythm Technologies Sees Boosted Price Target Following Strong Earnings - AInvest
Why Are iRhythm Technologies Shares Dropping? - TipRanks
Is It Too Late To Consider Buying IRhythm Technologies, Inc. (NASDAQ:IRTC)? - 富途牛牛
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
Volume Profile Shows Strong Base for iRhythm Technologies Inc.Smart Portfolio Optimization Tips - beatles.ru
iRhythm Technologies Inc. Crosses 200 Day MA — Signal or NoiseAI Powered High Return Stock Calls Dominate Watchlists - metal.it
What is the risk reward ratio of investing in iRhythm Technologies Inc. stockMaximize portfolio growth with strategic plans - Jammu Links News
What analysts say about iRhythm Technologies Inc. stockRapidly growing investment returns - Jammu Links News
How strong is iRhythm Technologies Inc. company’s balance sheetCapitalize on momentum-driven stocks - Jammu Links News
iRhythm’s Strategic Moves and Strong Q2 Performance Boost Stock - StocksToTrade
When is iRhythm Technologies Inc. stock expected to show significant growthUnlock superior stock analysis tools - Jammu Links News
How volatile is iRhythm Technologies Inc. stock compared to the marketTap into rapid wealth building techniques - Jammu Links News
Is iRhythm Technologies Inc. a growth stock or a value stockExponential return rates - Jammu Links News
What catalysts could drive iRhythm Technologies Inc. stock higher in 2025Achieve consistent profits with proven strategies - Jammu Links News
Is it the right time to buy iRhythm Technologies Inc. stockMaximize portfolio value with smart investment plans - Jammu Links News
How many analysts rate iRhythm Technologies Inc. as a “Buy”Identify breakout stocks before they peak - Jammu Links News
How does iRhythm Technologies Inc. compare to its industry peersBuild a diversified portfolio for risk management - Jammu Links News
What are the latest earnings results for iRhythm Technologies Inc.Tremendous return rates - Jammu Links News
Does iRhythm Technologies Inc. stock perform well during market downturnsBuild wealth steadily with smart stock selection - Jammu Links News
What institutional investors are buying iRhythm Technologies Inc. stockGame-changing capital returns - Jammu Links News
What are iRhythm Technologies Inc. company’s key revenue driversRapid profit acceleration - Jammu Links News
iRhythm Technologies Reports Strong Q2 2025 Earnings - The Globe and Mail
iRhythm Technologies (IRTC): Is This MedTech Innovator Poised for Sustained Growth Amid Strategic AI Collaborations and Strong Q2 Performance? - AInvest
iRhythm Technologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
IRTC’s Impressive Growth: What’s Next? - timothysykes.com
IRTC’s Big Leap: Exploring Recent Moves - StocksToTrade
Sensus Healthcare shares rise 1.61% intraday after IRhythm and Lucem Health partnership for predictive AI in arrhythmia detection. - AInvest
Is iRhythm Technologies Inc. stock overvalued or undervaluedEarnings Report Alerts For Every Investor - Jammu Links News
iRhythm’s Big Leap: Is It Sustainable? - timothysykes.com
iRhythm’s Strategic Moves: Market Impact? - StocksToTrade
iRhythm Technologies Surges 16.6% on Earnings Beat and AI Partnership: What’s Fueling This Breakout? - AInvest
iRhythm (IRTC) Stock Trades Up, Here Is Why - Yahoo Finance
iRhythm (IRTC) Q2 Revenue Jumps 26% - The Globe and Mail
Finanzdaten der Irhythm Technologies Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):